ICARES Medicus, Inc. (6612.TWO)
TWD 118.0
(0.0%)
TWD 118.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -25.78 Million | 128.91 Million | 38.56 Million | 71.37 Million | - |
| Net Income | 113.29 Million | 143.1 Million | 73.19 Million | 73.76 Million | - |
| Depreciation & Amortization | 43.73 Million | 28.31 Million | 28.69 Million | 30.04 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 20.13 Million | 9.79 Million | 11.12 Million | 5.45 Million | - |
| Change in working capital | -151.88 Million | -15.4 Million | -48.97 Million | 7.19 Million | - |
| Other non-cash items | -4.07 Million | -3.85 Million | 13.54 Million | 47 Thousand | - |
| Investing Cash Flow | -527.58 Million | -202.55 Million | -6.59 Million | -99.35 Million | - |
| Investments in PPE | -76.47 Million | -34.03 Million | -6.47 Million | -11.19 Million | - |
| Acquisitions | 88.37 Million | -43.43 Million | - | -47.96 Million | - |
| Investment purchases | -676.97 Million | -197.2 Million | - | -60.37 Million | - |
| Sales/Maturities of investments | 227.51 Million | 73.57 Million | - | - | - |
| Other Investing Activities | -1.64 Million | -1.45 Million | -129 Thousand | -12.29 Million | - |
| Financing Cash Flow | 656.09 Million | -23.88 Million | 46.56 Million | 5.68 Million | - |
| Debt repayment | -18.03 Million | - | - | - | -924 Thousand |
| Dividends payments | -34.16 Million | -16.98 Million | -3.39 Million | -16.86 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 598.43 Million | - | - | - | 2.19 Million |
| Other Financing Activities | 109.86 Million | 1.38 Million | 58.08 Million | 29.33 Million | - |
| Accounts receivables | -33.28 Million | - | - | - | - |
| Accounts payables | -1.75 Million | - | - | - | - |
| Inventory | -50.33 Million | -20.82 Million | -9.48 Million | -902 Thousand | - |
| Other working capital | -68.27 Million | - | - | - | - |
| Cash at beginning of period | 284.59 Million | 356.25 Million | 281.34 Million | 310.45 Million | - |
| Cash at end of period | 381.26 Million | 284.59 Million | 356.25 Million | 281.34 Million | - |
| Capital Expenditure | -76.47 Million | -34.03 Million | -6.47 Million | -11.19 Million | - |
| Effect of forex changes on cash | -6.05 Million | 25.86 Million | -3.62 Million | -6.81 Million | - |
| Net cash flow / Change in cash | 96.67 Million | -71.66 Million | 74.91 Million | -29.11 Million | - |
| Free Cash Flow | -102.26 Million | 94.88 Million | 32.09 Million | 60.17 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 30.49 Million | 38.17 Million | 113.29 Million | -8.49 Million | 44.34 Million | 46.47 Million |
| Depreciation & Amortization | 16.64 Million | 13.24 Million | 43.73 Million | 12.52 Million | 11.57 Million | 10.83 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 16.84 Million | 3.72 Million | 20.13 Million | 12.57 Million | 2.66 Million | 2.1 Million |
| Change in working capital | -92.83 Million | -41.7 Million | -151.88 Million | 4.7 Million | -114.79 Million | -28.66 Million |
| Other non-cash items | -9.27 Million | -3.45 Million | -4.07 Million | 5.59 Million | -4.6 Million | -869 Thousand |
| Investing Cash Flow | 12.5 Million | 3.15 Million | -527.58 Million | -403.92 Million | -94.71 Million | -35.78 Million |
| Investments in PPE | -2.72 Million | -25.54 Million | -76.47 Million | -15.69 Million | -4.31 Million | -34.6 Million |
| Acquisitions | 1.71 Million | - | - | - | - | - |
| Investment purchases | -285.07 Million | -425.54 Million | -676.97 Million | -186.06 Million | -304.92 Million | -62.39 Million |
| Sales/Maturities of investments | 272.02 Million | 453.3 Million | 227.51 Million | -202.18 Million | 214.57 Million | 62.19 Million |
| Other Investing Activities | 84 Thousand | -439 Thousand | -1.64 Million | 20 Thousand | -50 Thousand | -986 Thousand |
| Financing Cash Flow | 623.77 Million | -5.42 Million | 656.09 Million | 468.02 Million | 222.23 Million | -37.15 Million |
| Debt repayment | -5.92 Million | - | - | - | - | - |
| Dividends payments | - | - | -34.16 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 598.43 Million | - | - | - |
| Other Financing Activities | 629.7 Million | - | 109.86 Million | -124.88 Million | 227.67 Million | - |
| Accounts receivables | -9.89 Million | - | - | - | - | - |
| Accounts payables | 2.72 Million | - | - | - | - | - |
| Inventory | -27.13 Million | -18.77 Million | -50.33 Million | -9.19 Million | -16.45 Million | -19.89 Million |
| Other working capital | -55.08 Million | - | - | - | - | - |
| Cash at beginning of period | 402.94 Million | 381.26 Million | 284.59 Million | 332.96 Million | 259.87 Million | 325.62 Million |
| Cash at end of period | 981.75 Million | 402.94 Million | 381.26 Million | 381.26 Million | 332.96 Million | 259.87 Million |
| Capital Expenditure | -2.72 Million | -25.54 Million | -76.47 Million | -15.69 Million | -4.31 Million | -34.6 Million |
| Effect of forex changes on cash | 8.08 Million | 11.43 Million | -6.05 Million | -21.12 Million | 14.69 Million | 1 Million |
| Net cash flow / Change in cash | 578.81 Million | 21.67 Million | 96.67 Million | 48.3 Million | 73.08 Million | -65.74 Million |
| Free Cash Flow | -68.27 Million | -13.03 Million | -102.26 Million | -10.36 Million | -73.44 Million | -28.41 Million |
002723
4588
CBA
PRCNF
7229
3484